BioSpace News Archive

Biotech Bay

New Biotech Earns $85 Million in Series A Funding

Ambagon Therapeutics closes its first financing round with $85 million. The Series A funds will help advance the company’s drug discovery platform and molecular glue pipeline.

January 6, 2022
·
2 min read
·
Alvin Clavines
Business

SomaLogic and Illumina Combine Strengths to Propel Innovation in Proteomics

SomaLogic and Illumina have come together to propel innovation in Proteomics. This partnership represents the rapidly growing high throughput sector of the proteomics market

January 6, 2022
·
2 min read
·
Sreetama Dutt
Drug Development

Sangamo Searching for Options After Sanofi Withdraws from SCD Program

Sangamo Therapeutics announced that Sanofi US was returning its rights to SAR445136 as it shifts its approach from personalized cell therapies to allogeneic off-the-shelf genomic approaches.

January 6, 2022
·
4 min read
·
Mark Terry
Drug Development

Cartesian Aims to Propel RNA Cell Therapy with Combinations

Long-term, opportunities may include using the platform as a vehicle for combination therapies from assets developed by multiple companies.

January 6, 2022
·
4 min read
·
Gail Dutton
Deals

Eli Lilly Drops $50 Million+ for Entos’ Tech

Eli Lilly acquired rights to a technology from Entos Pharmaceuticals that boosts the development of nucleic acid therapeutics for the central and peripheral nervous system.

January 6, 2022
·
3 min read
·
Alex Keown
Business

Amgen Strikes Nearly $2 Billion Deal for Protein Therapeutics

Amgen and Generate Biomedicines inked a research partnership to discover and develop protein therapeutics for five clinical targets.

January 6, 2022
·
2 min read
·
Mark Terry
Business

Movers & Shakers, Jan. 7

With the turn of the calendar, biopharma and life sciences organizations have bolstered their leadership teams and board with these Movers & Shakers.

January 6, 2022
·
11 min read
·
Alex Keown
Biotech Beach

ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc

ICU Medical Inc. announced that it has completed its acquisition of Smiths Medical from Smiths Group plc.

January 6, 2022
·
5 min read
Pharm Country

Petros Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference and the Biotech Showcase 2022

Petros Pharmaceuticals, Inc., a leading provider of therapeutics for men’s health, announces that President and Chief Commercial Officer Fady Boctor will participate at the H.C. Wainwright Bioconnect 2022 Virtual Conference and the Biotech Showcase 2022.

January 6, 2022
·
1 min read
Genetown

Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference

Quanterix Corporation (NASDAQ: QTRX), today announced that its Chairman and Chief Executive Officer, and Founder of Powering Precision Health (PPH), Kevin Hrusovsky, will be presenting on the Company’s growth and vision for the sixth consecutive year at the 40th Annual J.P. Morgan Healthcare Conference.

January 6, 2022
·
2 min read